{
    "nctId": "NCT03762694",
    "briefTitle": "The Effect of Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy",
    "officialTitle": "The Effect of Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy: A Randomized, Wait-list Controlled Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Insomnia, Secondary, Breast Cancer Female, Chemotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Change in Insomnia Severity Index (ISI)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patients between 18 and 75 years of age;\n2. Diagnosis of stage (American Joint Committee on Cancer (AJCC) TNM) I-IV breast cancer;\n3. Currently receiving chemotherapy, or have completed chemotherapy no more than 6 months;\n4. Insomnia onset after the diagnosis of breast cancer;\n5. Insomnia occurs at least 3 nights per week, and presents for at least 1 month, with fulfilment of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnostic criteria for brief insomnia disorder;\n6. Insomnia severity as defined by an ISI score of no less than 10 in the past 2 weeks;\n7. Expected survival time of more than 6 months;\n8. Ability to understand the nature of the study and willingness to give informed consent;\n9. Ability to provide responses during outcome measurement.\n\nExclusion Criteria:\n\n1. Insomnia before the diagnosis of breast cancer;\n2. Other sleep disorder (e.g., obstructive sleep apnoea);\n3. Shift work or irregular sleep pattern;\n4. Severe visual, hearing or language defects;\n5. Severe hematological dysfunction (platelet count \\<60,000/\u03bcL, haemoglobin \\<8 g/dL or absolute neutrophil count \\<1000/\u03bcL);\n6. With pacemakers or other electronic implants that could interfere with electroacupuncture;\n7. History of acupuncture use in the previous 3 months;\n8. Participation in other clinical trials with intervention within 3 months of the beginning of the trial.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}